Technology
Reapplix offers a novel mechanism to enhance the inherent wound healing capability of the body - the LeucoPatch™. The LeucoPatch™ is made entirely from the patient's own blood without any additives and is therefore fully autologous and biocompatible.
Value Proposition
Reapplix' objective is to enable patients to benefit from the wound-healing properties of their own growth promoting factors and thereby provide a treatment option to avoid traumatic amputation surgery. Leucopatch™ increases the healing rate of chronically hard to heal and debilitating wounds thus resulting in increased quality of life for the patient and considerably lower costs for the society. Initially efforts focus on non-healing diabetic foot ulcers.
Pre-clinical trials have shown impressive results.
Additional Information
